Industry: Chemical & Material
Published Date: 2026-04-21
Pages: 130 Pages
Report ld: 6553416
Request Sample
Customized Report
The global Naproxen Active Pharmaceutical Ingredients market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Naproxen Active Pharmaceutical Ingredients competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Common side effects include dizziness, headache, bruising, allergic reactions, heartburn, and stomach pain. Severe side effects include an increased risk of heart disease, stroke, gastrointestinal bleeding, and stomach ulcers. The heart disease risk may be lower than with other NSAIDs. It is not recommended in people with kidney problems. Use is not recommended in the third trimester of pregnancy.
Naproxen is a nonselective COX inhibitor. It is in the propionic acid class of medications. As an NSAID, naproxen appears to exert its anti-inflammatory action by reducing the production of inflammatory mediators called prostaglandins. It is metabolized by the liver to inactive metabolites.
Naproxen was patented in 1967, and approved for medical use in the United States in 1976. It is available over the counter and as a generic medication. In 2017, it was the 71st most commonly prescribed medication in the United States, with more than eleven million prescriptions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Naproxen Active Pharmaceutical Ingredients market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Naproxen Active Pharmaceutical Ingredients. The Naproxen Active Pharmaceutical Ingredients market size, estimates, and forecasts are provided in terms of output/shipments (Kiloton) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Naproxen Active Pharmaceutical Ingredients market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Naproxen Active Pharmaceutical Ingredients manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Naproxen Active Pharmaceutical Ingredients manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Naproxen Active Pharmaceutical Ingredients production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Naproxen Active Pharmaceutical Ingredients consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Naproxen Active Pharmaceutical Ingredients Market Overview
1.1 Product Definition
1.2 Naproxen Active Pharmaceutical Ingredients by Type
1.2.1 Global Naproxen Active Pharmaceutical Ingredients Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Purity (99%-99.5%)
1.2.3 Purity (above 99.5%)
1.2.4 Purity (below 99 %)
1.3 Naproxen Active Pharmaceutical Ingredients by Application
1.3.1 Global Naproxen Active Pharmaceutical Ingredients Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Treat pain
1.3.3 Menstrual cramps
1.3.4 Inflammatory diseases
1.3.5 Fever
1.3.6 Others
1.4 Global Market Growth Prospects
1.4.1 Global Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Naproxen Active Pharmaceutical Ingredients Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Naproxen Active Pharmaceutical Ingredients Production Estimates and Forecasts (2021–2032)
1.4.4 Global Naproxen Active Pharmaceutical Ingredients Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Naproxen Active Pharmaceutical Ingredients Production Market Share by Manufacturers (2021–2026)
2.2 Global Naproxen Active Pharmaceutical Ingredients Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Naproxen Active Pharmaceutical Ingredients, Industry Ranking, 2024 vs 2025
2.4 Global Naproxen Active Pharmaceutical Ingredients Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Naproxen Active Pharmaceutical Ingredients Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Naproxen Active Pharmaceutical Ingredients, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Naproxen Active Pharmaceutical Ingredients, Product Offerings and Applications
2.8 Global Key Manufacturers of Naproxen Active Pharmaceutical Ingredients, Date of Entry into the Industry
2.9 Naproxen Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.9.1 Naproxen Active Pharmaceutical Ingredients Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Naproxen Active Pharmaceutical Ingredients Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Naproxen Active Pharmaceutical Ingredients Production by Region
3.1 Global Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Region (2021–2032)
3.2.1 Global Naproxen Active Pharmaceutical Ingredients Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Naproxen Active Pharmaceutical Ingredients by Region (2027–2032)
3.3 Global Naproxen Active Pharmaceutical Ingredients Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Naproxen Active Pharmaceutical Ingredients Production Volume by Region (2021–2032)
3.4.1 Global Naproxen Active Pharmaceutical Ingredients Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Naproxen Active Pharmaceutical Ingredients by Region (2027–2032)
3.5 Global Naproxen Active Pharmaceutical Ingredients Market Price Analysis by Region (2021–2032)
3.6 Global Naproxen Active Pharmaceutical Ingredients Production, Value, and Year-over-Year Growth
3.6.1 North America Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Naproxen Active Pharmaceutical Ingredients Production Value Estimates and Forecasts (2021–2032)
4 Naproxen Active Pharmaceutical Ingredients Consumption by Region
4.1 Global Naproxen Active Pharmaceutical Ingredients Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Naproxen Active Pharmaceutical Ingredients Consumption by Region (2021–2032)
4.2.1 Global Naproxen Active Pharmaceutical Ingredients Consumption by Region (2021–2026)
4.2.2 Global Naproxen Active Pharmaceutical Ingredients Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Naproxen Active Pharmaceutical Ingredients Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Naproxen Active Pharmaceutical Ingredients Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Naproxen Active Pharmaceutical Ingredients Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Naproxen Active Pharmaceutical Ingredients Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Naproxen Active Pharmaceutical Ingredients Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Naproxen Active Pharmaceutical Ingredients Production by Type (2021–2032)
5.1.1 Global Naproxen Active Pharmaceutical Ingredients Production by Type (2021–2026)
5.1.2 Global Naproxen Active Pharmaceutical Ingredients Production by Type (2027–2032)
5.1.3 Global Naproxen Active Pharmaceutical Ingredients Production Market Share by Type (2021–2032)
5.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Type (2021–2032)
5.2.1 Global Naproxen Active Pharmaceutical Ingredients Production Value by Type (2021–2026)
5.2.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Type (2027–2032)
5.2.3 Global Naproxen Active Pharmaceutical Ingredients Production Value Market Share by Type (2021–2032)
5.3 Global Naproxen Active Pharmaceutical Ingredients Price by Type (2021–2032)
6 Segment by Application
6.1 Global Naproxen Active Pharmaceutical Ingredients Production by Application (2021–2032)
6.1.1 Global Naproxen Active Pharmaceutical Ingredients Production by Application (2021–2026)
6.1.2 Global Naproxen Active Pharmaceutical Ingredients Production by Application (2027–2032)
6.1.3 Global Naproxen Active Pharmaceutical Ingredients Production Market Share by Application (2021–2032)
6.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Application (2021–2032)
6.2.1 Global Naproxen Active Pharmaceutical Ingredients Production Value by Application (2021–2026)
6.2.2 Global Naproxen Active Pharmaceutical Ingredients Production Value by Application (2027–2032)
6.2.3 Global Naproxen Active Pharmaceutical Ingredients Production Value Market Share by Application (2021–2032)
6.3 Global Naproxen Active Pharmaceutical Ingredients Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Xinhua Pharm
7.1.1 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Company Information
7.1.2 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.1.3 Xinhua Pharm Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Xinhua Pharm Main Business and Markets Served
7.1.5 Xinhua Pharm Recent Developments/Updates
7.2 Granules India Limited
7.2.1 Granules India Limited Naproxen Active Pharmaceutical Ingredients Company Information
7.2.2 Granules India Limited Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.2.3 Granules India Limited Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Granules India Limited Main Business and Markets Served
7.2.5 Granules India Limited Recent Developments/Updates
7.3 Huagang Pharm
7.3.1 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Company Information
7.3.2 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.3.3 Huagang Pharm Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Huagang Pharm Main Business and Markets Served
7.3.5 Huagang Pharm Recent Developments/Updates
7.4 Hebei Jiheng Pharmaceutical
7.4.1 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Company Information
7.4.2 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.4.3 Hebei Jiheng Pharmaceutical Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Hebei Jiheng Pharmaceutical Main Business and Markets Served
7.4.5 Hebei Jiheng Pharmaceutical Recent Developments/Updates
7.5 The Perrigo Company
7.5.1 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Company Information
7.5.2 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.5.3 The Perrigo Company Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 The Perrigo Company Main Business and Markets Served
7.5.5 The Perrigo Company Recent Developments/Updates
7.6 Taj Pharmaceuticals Ltd
7.6.1 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Company Information
7.6.2 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.6.3 Taj Pharmaceuticals Ltd Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Taj Pharmaceuticals Ltd Main Business and Markets Served
7.6.5 Taj Pharmaceuticals Ltd Recent Developments/Updates
7.7 LGM Pharma
7.7.1 LGM Pharma Naproxen Active Pharmaceutical Ingredients Company Information
7.7.2 LGM Pharma Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.7.3 LGM Pharma Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 LGM Pharma Main Business and Markets Served
7.7.5 LGM Pharma Recent Developments/Updates
7.8 Iwaki Seiyaku
7.8.1 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Company Information
7.8.2 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.8.3 Iwaki Seiyaku Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Iwaki Seiyaku Main Business and Markets Served
7.8.5 Iwaki Seiyaku Recent Developments/Updates
7.9 Atom pharma
7.9.1 Atom pharma Naproxen Active Pharmaceutical Ingredients Company Information
7.9.2 Atom pharma Naproxen Active Pharmaceutical Ingredients Product Portfolio
7.9.3 Atom pharma Naproxen Active Pharmaceutical Ingredients Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Atom pharma Main Business and Markets Served
7.9.5 Atom pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Naproxen Active Pharmaceutical Ingredients Industry Chain Analysis
8.2 Naproxen Active Pharmaceutical Ingredients Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Naproxen Active Pharmaceutical Ingredients Production Modes and Processes
8.4 Naproxen Active Pharmaceutical Ingredients Sales and Marketing
8.4.1 Naproxen Active Pharmaceutical Ingredients Sales Channels
8.4.2 Naproxen Active Pharmaceutical Ingredients Distributors
8.5 Naproxen Active Pharmaceutical Ingredients Customer Analysis
9 Naproxen Active Pharmaceutical Ingredients Market Dynamics
9.1 Naproxen Active Pharmaceutical Ingredients Industry Trends
9.2 Naproxen Active Pharmaceutical Ingredients Market Drivers
9.3 Naproxen Active Pharmaceutical Ingredients Market Challenges
9.4 Naproxen Active Pharmaceutical Ingredients Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Naproxen Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 128
USD 3950.00
(Single User License)
The global Naproxen Active Pharmaceutical Ingredients market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-21
Pages: 147
USD 4900.00
(Single User License)
The global market for Naproxen Active Pharmaceutical Ingredients was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
The global market for Naproxen Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 110
USD 3950.00
(Single User License)
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published Date: 2024-04-16
Pages: 89
USD 4900.00
(Single User License)
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published Date: 2024-02-21
Pages: 100
USD 3950.00
(Single User License)
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published Date: 2024-01-08
Pages: 85
USD 2900.00
(Single User License)
The global market for Naproxen Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 128
The global Naproxen Active Pharmaceutical Ingredients market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-21
Pages: 147
The global market for Naproxen Active Pharmaceutical Ingredients was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
The global market for Naproxen Active Pharmaceutical Ingredients was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 110
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published: 2024-04-16
Pages: 89
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published: 2024-02-21
Pages: 100
Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, inflammatory diseases such as rheumatoid arthritis, and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and last for up to twelve hours.
Published: 2024-01-08
Pages: 85
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now